Navigation Links
Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
Date:10/29/2009

instruments, net of $2,005 as well as a gain on the extinguishment of a portion of the debt acquired from Indevus of $4,025.
  • To reflect the cash tax savings resulting from the Indevus acquisition and the tax effect of the pre-tax adjustments above at applicable tax rates.
  •     Nine months Ended         Actual
         September 30, 2008      Reported
         (unaudited)               (GAAP)  Adjustments        Adjusted
    
        Total Revenues           $913,200            $        $913,200
        Costs and expenses:
          Cost of revenues        190,554      (21,944)  (1)   168,610
          Selling, general and
           administrative         357,775      (12,481)  (2)   345,294
          Research and
           development             82,244      (10,491)  (3)    71,753
          Impairment of other
           intangibles              8,083       (8,083)  (4)
    
        Operating income          274,544       52,999         327,543
    
          Interest income, net     (8,292)      (6,620)  (5)   (14,912)
          Other income, net          (835)                        (835)
    
        Income before income
         taxes                    283,671       59,619         343,290
          Income taxes            101,021       22,631   (6)   123,652
    
        Net income               $182,650      $36,988        $219,638
    
        Diluted earnings per share  $1.45           --           $1.74
        Diluted weighted
         average shares           126,012           --         126,012
    
    
    
    

    Notes to reconciliation of our GAAP statements of operations to our adjusted statements of operations:

    1. To exclude amortization of commercial intangible assets related to marketed products.
    2. To exclude separation costs of $10,459, impairment of long-lived assets of $1,482 and contract termination costs of $540.
    3. To exclude upfront and milestone payments to partners of $2,000, separation costs of $825, impairment of long lived assets of $3,115 and contract termination costs of $4,551.
    4. To exc
      '/>"/>

    SOURCE Endo Pharmaceuticals
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
    2. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
    3. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
    4. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
    5. DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
    6. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
    7. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
    8. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
    9. Bellicum Pharmaceuticals Announces $4.5 Million in New Funding
    10. BioMarin Acquires Huxley Pharmaceuticals, Inc.
    11. Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... , Jan. 23, 2015 More than a third ... quarter of those with private insurance, filled a prescription for ... a report in this week,s Morbidity and Mortality Weekly Report ... care providers to treat moderate to severe pain.  They are ...
    (Date:1/23/2015)... MERIDIAN, Idaho , Jan. 23, 2015  Now available ... Patent No. 7,849,611) support that prevents ankle sprains by ... a brace, it fits securely around the outside of ... ankle mobility & comfort while still offering protection against ...
    (Date:1/23/2015)... 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a critical ... adsorber to reduce deadly inflammation in critically-ill and ... net of transaction costs, in non-dilutive funding as ... Certificate Transfer Program sponsored by the New Jersey ...
    Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
    (Date:1/22/2015)... Dallas, TX (PRWEB) January 22, 2015 ... the issue of experience and person-centeredness in the long-term ... moving towards action across the continuum. The paper, “The ... the Continuum,” engages perspectives and practices of the patient, ...
    (Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that ... And for those same twenty-plus years, the team at Doctors ... with the best possible doctor. With the combined breadth ...
    (Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
    (Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative ... design to treat specific body parts and muscle groups. , ... easy to use patented cold therapy machine with the innovative ... and muscle injuries. IsoComforter has become the industry leader ...
    (Date:1/22/2015)... January 22, 2015 EBSCO Information Services ... are expanding their relationship in an effort to further promote ... world. While EBSCO has long made AMA journals available via ... agent for The JAMA Network. , Long known ...
    Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
    ... Cold Spring Harbor, NY -- A team of neuroscientists at ... UC San Diego (UCSD) has collected evidence suggesting that a ... locus of human depression. In two rat ... in a tiny area in the central brain called the ...
    ... HealthDay Reporter , WEDNESDAY, Feb. 23 (HealthDay ... pain -- an increasingly controversial treatment that has exploded ... to higher rates of permanent disability for worker,s compensation ... finds. Researchers randomly selected 725 people with low ...
    ... By Amanda Gardner HealthDay Reporter , TUESDAY, Feb. ... the areas of your brain closest to the phone,s antenna, ... effects pose any long-term health risk. "We don,t know ... potential beneficial effects. We don,t know one way or the ...
    ... a rock concert, noise-induced hearing loss is one of the ... School of Medicine in St. Louis have identified a low-dose, ... before they are exposed to loud noise. The drugs, already ... exposure. While both drugs are known to protect hearing ...
    ... San Francisco, CA February 22, 2011 The ... million in research grants as part of its Mobilizing ... populations with chronic diseases through the use of mobile-phone ... $250,000 each, will support studies on diabetes care and ...
    ... News) -- Moderate alcohol consumption may help protect against heart ... One team at the University of Calgary reviewed 84 ... that people who drink alcohol in moderation (one drink or ... likely to develop heart disease as those who don,t drink ...
    Cached Medicine News:Health News:Neuroscientists find overlooked brain area is an important locus of depression 2Health News:Neuroscientists find overlooked brain area is an important locus of depression 3Health News:Spinal Fusion Surgery May Leave Some Back Pain Patients Worse Off: Study 2Health News:Spinal Fusion Surgery May Leave Some Back Pain Patients Worse Off: Study 3Health News:Cell Phones Affect Areas of the Brain, Study Shows 2Health News:Cell Phones Affect Areas of the Brain, Study Shows 3Health News:2 drugs protect hearing better than 1 2Health News:McKesson Foundation awards $1.3 million in 6 Mobilizing for Health Research grants 2Health News:More Evidence Ties Moderate Drinking to Heart Health 2
    Custom programming of 3 hot blocks and 1 cold block, 30% reduction in cycling time, Unmatched well-to-well uniformity, No gradient feature...
    ... is the first instrument engineered to match ... rapid temperature cycling system is based on ... contained in microcapillary tubes or thin walled ... with blasts of high velocity air results ...
    ... Excellent performance, small footprint, simple intuitive programming ... Primus 25 the ideal personal cycler in ... flexiblock design and the self-adjusting heated lid ... 13x 0.5ml vessels or a microplate of ...
    ... Ideal for day-to-day ... uniformity of 0.1C ,30% ... over Peltier or coolant-based ... eliminate temperature ramping ,Options ...
    Medicine Products: